MEDSYN BIOPHARMA LLC

Profile

Company Names

MEDSYN BIOPHARMA LLC

Addresses

120 W MAIN ST., STE 300, NORTHVILLE, MI 48167-1584

2 WEST LIBERTY BLVD., SUITE 110, MALVERN, PA 19355

Phone Numbers

(610) 725-1500

 

Entity Type:

LIMITED LIABILITY COMPANY

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$19,589,999.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-10-20 
$11,499,999.00 
$11,500,000.00 
$1.00 
Equity 
2
2024-07-31 
$5,000,000.00 
$5,000,000.00 
$0.00 
Equity 
1
2023-02-09 
$3,090,000.00 
$3,090,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MEL 
SORENSEN 
JOHN 
EXECUTIVE OFFICER, DIRECTOR
MEDSYN BIOPHARMA LLC
MARTIN 
 
MATTHEW 
EXECUTIVE OFFICER
MEDSYN BIOPHARMA LLC
GILBERT 
S. 
OMENN 
DIRECTOR
AMGEN INC   |  ESPERION THERAPEUTICS, INC.   |  MEDSYN BIOPHARMA LLC
JOHN 
MEL 
SORENSEN 
EXECUTIVE OFFICER, DIRECTOR
MEDSYN BIOPHARMA LLC   |  ESANIK THERAPEUTICS, INC.
SHAOMENG 
 
WANG 
DIRECTOR
ONCOFUSION THERAPEUTICS, INC.   |  ONCOPIA THERAPEUTICS, LLC   |  W+F OT INVESTMENT LLC   |  MEDSYN BIOPHARMA LLC
BRIAN 
 
WOOD 
EXECUTIVE OFFICER
BULB INC.   |  ONCOPIA THERAPEUTICS, LLC   |  VENTAS LIFE SCIENCE + HEALTHCARE REAL ESTATE FUND, L.P.   |  MEDSYN BIOPHARMA LLC   |  BC WOOD REAL ESTATE FUND IV, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-11-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2025-10-20 
2024-08-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-31 
2023-03-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-02-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#